Crossmark Global Holdings, Inc. Abbott Laboratories Transaction History

Crossmark Global Holdings, Inc.

$5.22 Billion
Q1 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 331,556 shares of ABT stock, worth $34.5 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

331,556

Previous 348,271 4.8%

Holding current value

$34.5 Million

Previous $38.3 Million 1.69%

% of portfolio

0.72%

Previous 0.8%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $1.83 Million - $2.02 Million	-16,715 Reduced 4.8%	331,556 $37.7 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $2.48 Million - $3.04 Million	27,527 Added 8.58%	348,271 $38.3 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $12.3 Million - $14.8 Million	128,779 Added 67.08%	320,744 $31.3 Million
Q2 2023 Jul 31, 2023	SELL	$100.78 - $112.29 $9.43 Million - $10.5 Million	-93,543 Reduced 32.76%	191,965 $21.6 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $607,312 - $714,842	6,270 Added 2.25%	285,508 $28.9 Million

Q4 2022 Jan 19, 2023	BUY	$95.06 - $111.52 $512,468 - $601,204	5,391 Added 1.97%	279,238 $30.7 Million
Q3 2022 Nov 01, 2022	SELL	$96.76 - $112.03 $2.38 Million - $2.76 Million	-24,629 Reduced 8.25%	273,847 $26.5 Million
Q2 2022 Jul 29, 2022	SELL	$102.07 - $123.37 $499,428 - $603,649	-4,893 Reduced 1.61%	298,476 $32.4 Million
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $563,372 - $686,996	4,941 Added 1.66%	303,369 $35.9 Million
Q4 2021 Jan 10, 2022	SELL	$115.53 - $141.46 $2.57 Million - $3.14 Million	-22,230 Reduced 6.93%	298,428 $42 Million
Q3 2021 Oct 21, 2021	BUY	$116.66 - $129.06 $20.9 Million - $23.1 Million	179,278 Added 126.81%	320,658 $37.9 Million
Q3 2021 Oct 13, 2021	SELL	$116.66 - $129.06 $23.5 Million - $26 Million	-201,150 Reduced 58.72%	141,380 $9.69 Million
Q2 2021 Jul 21, 2021	BUY	$105.79 - $124.53 $10.8 Million - $12.7 Million	102,089 Added 42.46%	342,530 $39.7 Million
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $1.98 Million - $2.33 Million	-18,173 Reduced 7.03%	240,441 $28.8 Million
Q4 2020 Jan 14, 2021	SELL	$105.0 - $114.42 $12.1 Million - $13.2 Million	-114,949 Reduced 30.77%	258,614 $28.3 Million
Q3 2020 Oct 08, 2020	SELL	$91.64 - $111.29 $1.35 Million - $1.64 Million	-14,753 Reduced 3.8%	373,563 $40.7 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $1.2 Million - $1.53 Million	-15,622 Reduced 3.87%	388,316 $35.5 Million
Q1 2020 Apr 28, 2020	BUY	$62.82 - $91.86 $6.13 Million - $8.97 Million	97,646 Added 31.88%	403,938 $31.9 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $511,257 - $569,148	-6,512 Reduced 2.08%	306,292 $26.6 Million
Q3 2019 Oct 09, 2019	BUY	$81.84 - $88.74 $570,834 - $618,961	6,975 Added 2.28%	312,804 $26.2 Million
Q2 2019 Jul 09, 2019	SELL	$72.88 - $85.0 $540,186 - $630,020	-7,412 Reduced 2.37%	305,829 $25.7 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $2.14 Million - $2.59 Million	-32,390 Reduced 9.37%	313,241 $25 Million
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $500,222 - $566,680	-7,630 Reduced 2.16%	345,631 $25 Million
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $1.11 Million - $1.34 Million	-18,271 Reduced 4.92%	353,261 $25.9 Million
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $87,391 - $96,453	-1,518 Reduced 0.41%	371,532 $22.7 Million
Q1 2018 Apr 16, 2018	SELL	$56.27 - $63.62 $420,899 - $475,877	-7,480 Reduced 1.97%	373,050 $22.4 Million
Q4 2017 Feb 05, 2018	SELL	$53.68 - $57.47 $581,676 - $622,744	-10,836 Reduced 2.77%	380,530 $21.7 Million
Q3 2016 Oct 25, 2017	BUY	N/A	391,366	391,366 $20.9 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Abbott Laboratories Transaction History